FLCN - Investor Ideas adds New Cannabis Stocks
Point Roberts, WA and Delta, BC - October 4, 2019 (Investorideas.com Newswire) Investorideas.com, a global news source and investor resource covering cannabis and hemp stocks announces this week's additions to its cannabis /hemp stock directory for investors following the sector.
This week's new additions include three companies involved in the CBD industry, and GreenStar Biosciences Corp. (CSE: GSTR), a growth-oriented technology and services company that provides real estate, financial, management, IP and branding support to licensed cannabis businesses in the United States
This week's new Marijuana/Cannabis Stocks Added to the Investor cannabis stock directory:
InnoCan Pharma Corporation (CSE:INNO) business can be described as three distinct operating segments relating to the incorporation in products of CBD in their formulation: (i) research, development, marketing, distribution and sales of InnoCan-branded OTC pharmaceutical products; (ii) research and development of non-pharmaceutical products for third parties in exchange for fees and/or royalties; and (iii) research and development of hydrogels containing liposomes intended for licensing or sale to third party pharmaceutical corporations for manufacturing, distribution and sales.
Falcon Technologies, Inc (OTC PINK: FLCN) is a company focused on the marketing, sale, and distribution of CBD products and other products derived from industrial hemp.
HQ Global Education (OTC: HQGE) is a Delaware corporation dedicated to becoming the industry leader in data gathering, intelligence and education for the industrial CBD industry in America, and to playing a major role in helping to fill the enormous global demand for CBD oil and related products, the market for which is exploding since it has been proven to provide enormous health and medical benefits for a wide range of ailments and illnesses. HQ Global Education acquired Hempsession in June 2019 and Green Sky Solutions, Inc. in September 2019
GreenStar Biosciences Corp. (CSE: GSTR) is a growth-oriented technology and services company that provides real estate, financial, management, IP and branding support to licensed cannabis businesses in the United States. GreenStar operates a growing portfolio of tenant partner companies in the United States. GreenStar applies refined strategies tested in the Washington State market to help partner companies reach their full potential. Based in Vancouver, BC, GreenStar intends to facilitate growth through acquisitions and development of additional assets, products and technologies in legal cannabis markets by leveraging its capital markets, branding and operational expertise.
For investors following the sector Investor Ideas has created a stock directory of publicly traded CSE, TSX, TSXV, OTC, NASDAQ, NYSE, ASX Marijuana / Hemp Stocks. Visit directory.
Investorideas.com global stock directories are part of the membership program on the site, accessed either by login and password or available in PDF format. The directories include stocks trading on the TSX, OTC, NASDAQ, NYSE and other recognized global stock exchanges, giving retail investors a wide variety of stocks to review.
https://www.investorideas.com/membership/
The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Learn more about our news, PR and social media services at Investorideas.com
https://www.investorideas.com/Investors/Services.asp
Follow us on cannabis social media
https://www.facebook.com/Investorideaspotcasts/
https://twitter.com/MJInvestorIdeas
https://www.instagram.com/potcasts_investorideas/
Download our Mobile App for iPhone and Android
To sponsor a daily podcast for the month or to be an expert guest please contact us!
Contact Investorideas.com
800-665-0411